5-fluorouracil

You have access
Synergistic Antiproliferative Effect of Ribociclib (LEE011) and 5-Fluorouracil on Human Colorectal Cancer
PAI-MEI LIN, HUI-MING LEE, CHUNG-I HUANG, TZONG-SHYUAN TAI, JIAN-HAN CHEN, CHIH-I CHEN and YU-CHIEH SU

Anticancer Research November 2020, 40 (11) 6265-6271; DOI: https://doi.org/10.21873/anticanres.14647
You have access
A Gemcitabine Plus 5-Fluorouracil Combination Inhibits Gastric-Cancer Liver Metastasis in a PDOX Model: A Novel Treatment Strategy
NORIHIKO SUGISAWA, HIROTO NISHINO, TAKASHI HIGUCHI, JUN HO PARK, JUN YAMAMOTO, YOSHIHIKO TASHIRO, KEI KAWAGUCHI, MICHAEL BOUVET, MICHIAKI UNNO and ROBERT M. HOFFMAN

Anticancer Research October 2020, 40 (10) 5393-5397; DOI: https://doi.org/10.21873/anticanres.14547
You have access
Expression of ATP-binding Cassette Transporter 11 (ABCC11) Protein in Colon Cancer
YASUFUMI YAMADA, KAZUHIKO YOSHIMATSU, HAJIME YOKOMIZO, SACHIYO OKAYAMA and SHUNICHI SHIOZAWA

Anticancer Research October 2020, 40 (10) 5405-5409; DOI: https://doi.org/10.21873/anticanres.14549
You have access
Casein Kinase 2α Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress
HYUNG JOO KIM, YONG-SEOK HAN, JUN HEE LEE and SANG HUN LEE

Anticancer Research March 2020, 40 (3) 1419-1426; DOI: https://doi.org/10.21873/anticanres.14083
You have access
VDR Agonists Increase Sensitivity of MCF-7 and BT-474 Breast Cancer Cells to 5 FU
DAGMARA KLOPOTOWSKA and JANUSZ MATUSZYK

Anticancer Research February 2020, 40 (2) 837-840; DOI: https://doi.org/10.21873/anticanres.14015
You have access
Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model
GUANGWEI ZHU, MING ZHAO, QINGHONG HAN, YUYING TAN, YU SUN, MICHAEL BOUVET, BRYAN CLARY, SHREE RAM SINGH, JIANXIN YE and ROBERT M. HOFFMAN

Anticancer Research December 2019, 39 (12) 6463-6470; DOI: https://doi.org/10.21873/anticanres.13860
You have access
Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model
GUANGWEI ZHU, MING ZHAO, QINGHONG HAN, YUYING TAN, YU SUN, MICHAEL BOUVET, SHREE RAM SINGH, JIANXIN YE and ROBERT M. HOFFMAN

Anticancer Research November 2019, 39 (11) 5999-6005; DOI: https://doi.org/10.21873/anticanres.13805
You have access
Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model
HIROMICHI OSHIRO, YASUNORI TOME, TASUKU KIYUNA, SANG NAM YOON, THINZAR M. LWIN, QINGHONG HAN, YUYING TAN, KENTARO MIYAKE, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, YUKI KATSUYA, JUN HO PARK, ZHIYING ZANG, SAHAR RAZMJOOEI, MICHAEL BOUVET, BRYAN CLARY, SHREE RAM SINGH, FUMINORI KANAYA, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research September 2019, 39 (9) 4667-4671; DOI: https://doi.org/10.21873/anticanres.13648
You have access
5-Aza-2-deoxycytidine Enhances the Sensitivity of 5-Fluorouracil by Demethylation of the Thymidine Phosphorylase Promoter
YUKIHIKO NISHIZAWA, RYUJI IKEDA, MASATATSU YAMAMOTO, KOHICHI KAWAHARA, YOSHINARI SHINSATO, KENTARO MINAMI, MINA NITTA, HIDEYUKI TERAZONO, SHIN-ICHI AKIYAMA, TATSUHIKO FURUKAWA and YASUO TAKEDA

Anticancer Research August 2019, 39 (8) 4129-4136; DOI: https://doi.org/10.21873/anticanres.13571
You have access
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
MATTHEW R. KEARNEY, EMERSON Y. CHEN, GINA M. VACCARO, JOHN STROTHER, ANDREA BURT, KENDRA TODD, JEFF DONOVAN, KERSTIN M. KAMPA-SCHITTENHELM and CHARLES D. LOPEZ

Anticancer Research January 2019, 39 (1) 245-252; DOI: https://doi.org/10.21873/anticanres.13104

Main menu

User menu

Search

5-fluorouracil

Pages